USFDA Archives

news

Alembic Pharmaceuticals announces USFDA Final Approval for Nelarabine Injection

2nd August 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug istration (USFDA) for its Abbreviated New Drug Application…

Rekha Nair August 2, 2024

news

Alembic Pharmaceuticals Receives USFDA Final Approval for Fluphenazine Hydrochloride Tablets

24th July 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug istration (USFDA) for its Abbreviated New Drug Application…

Sujata July 24, 2024

news

Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%

9thJuly 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug istration (USFDA) for its Abbreviated New Drug Application (ANDA)…

Mansi Praharaj July 9, 2024

news

Alembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mg

4 July 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug istration (USFDA) for its Abbreviated New Drug Application…

Mansi Praharaj July 4, 2024

Health

Alembic Pharmaceuticals announces USFDA Final Approval for Doxycycline Capsules, 40 mg

28th June 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug istration (USFDA) for its Abbreviated New Drug Application (ANDA)…

Mansi Praharaj June 28, 2024